A noninvasive sensor utilizing dielectric spectroscopy to scan radiofrequencies may accurately measure glucose levels, reducing waste, lowering costs, and making measurements pain and needle free for people with diabetes. This technology was highlighted at the American Association of Clinical Endocrinology Annual Meeting. Another top story discussed a study showing similar changes in cardiometabolic measures among men receiving lifestyle intervention plus testosterone therapy vs. placebo. Other top stories included challenges in treating pregnant women with diabetes, providers starting osteoporosis therapy without full assessment, and new guidance on thyroid nodule risk assessment. The potential of this noninvasive sensor and other advancements in endocrinology were emphasized in the latest updates.
Source link
Novel sensor for diabetes; metabolic effects of testosterone therapy
